Medtronic (MDT) Q1 2026 10-Q Quarterly Report
Filed: Feb 24, 2026Period ending Jan 23, 2026
Health Care
Electromedical & Electrotherapeutic ApparatusSEC EDGAR Medtronic (MDT) 10-Q quarterly report for Q1 2026, filed with SEC EDGAR on Feb 24, 2026 for the fiscal period ending Jan 23, 2026. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Medtronic Q1 2026 10-Q Analysis
Management Discussion & Analysis
- • Q3 FY2026 total net sales $9.0B, up ~9% YoY from $8.3B; nine-month sales $26.6B vs $24.6B prior year
- • GAAP effective tax rate 18.1% vs 15.4% YoY; GAAP net income $1.14B vs $1.29B YoY; non-GAAP EPS $1.36 vs $1.39 YoY
Risk Factors
- • Section 'risk_factors' was empty or not found.
Medtronic Q1 2026 Quarterly FinancialsXBRL
Revenue
$9.0B
▲ +8.8% YoY▲ +0.6% QoQ
Net Income
$1.1B
▼ -11.7% YoY▼ -16.8% QoQ
Operating Margin
16.2%
▼ -362bp YoY▼ -257bp QoQ
Net Margin
12.7%
▼ -293bp YoY▼ -266bp QoQ
ROE
2.3%
▼ -49bp QoQ
Total Assets
$91.5B
▲ +0.2% QoQ
EPS (Diluted)
$0.89
▼ -11.0% YoY▼ -16.0% QoQ
Operating Cash Flow
$2.7B
▲ +6.7% YoY▲ +196.6% QoQ
Source: XBRL data from Medtronic Q1 2026 10-Q filing on SEC EDGAR. All figures in USD.
Other Medtronic Quarterly Reports
Get deeper insights on Medtronic
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.